Matches in Nanopublications for { ?s ?p "[Generated anti-NLGP antibody (primarily IgG2a) was tested for its anti-tumor activity in murine carcinoma (EC, CT-26), sarcoma (S180) and melanoma (B16Mel) tumor models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1211235.RAqff0UWu19QqZEC_1-hlHLckfGBjP51EJjo4ehwmCj6A130_assertion description "[Generated anti-NLGP antibody (primarily IgG2a) was tested for its anti-tumor activity in murine carcinoma (EC, CT-26), sarcoma (S180) and melanoma (B16Mel) tumor models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211235.RAqff0UWu19QqZEC_1-hlHLckfGBjP51EJjo4ehwmCj6A130_provenance.
- NP1211236.RAtZWueJqi5X-7USyN-9dxYR5hMt4wEv1NQg7aTtnjZoU130_assertion description "[Generated anti-NLGP antibody (primarily IgG2a) was tested for its anti-tumor activity in murine carcinoma (EC, CT-26), sarcoma (S180) and melanoma (B16Mel) tumor models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211236.RAtZWueJqi5X-7USyN-9dxYR5hMt4wEv1NQg7aTtnjZoU130_provenance.